IGM Biosciences, Inc.
Hedge Funds Holdings
Last updated:
IGM Biosciences, Inc.‘s stocks are currently a part of 42 hedge funds’ portfolios, which represents 14.95% of the total amount of its stocks outstanding. This makes up a total of 6.21M shares of IGM Biosciences, Inc.. Compared to the previous quarter, the number fell by -65.45% or -11.76M shares fewer. As for the holding position changes, 42.86% (18) of current hedge fund investors increased the number of shares held, 38.1% (16) of current holders sold a part of the shares held, and 23.81% (10) closed the holdings completely. 1 hedge funds are new holders of IGM Biosciences, Inc. stock in Q1 2023, it is 2.38% of total holders.
Hedge funds holding IGM Biosciences (Q3 2019 – Q1 2023)
Q3 2019 | 33 |
---|---|
Q4 2019 | 50 |
Q1 2020 | 61 |
Q2 2020 | 80 |
Q3 2020 | 90 |
Q4 2020 | 104 |
Q1 2021 | 108 |
Q2 2021 | 104 |
Q3 2021 | 105 |
Q4 2021 | 84 |
Q1 2022 | 92 |
Q2 2022 | 88 |
Q3 2022 | 89 |
Q4 2022 | 81 |
Q1 2023 | 42 |
Hedge funds changes in IGM Biosciences positions (Q3 2019 – Q1 2023)
Q3 2019 | 33 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q4 2019 | 33 | 6 | 4 | 10 | -3 |
Q1 2020 | 20 | 16 | 17 | 9 | -1 |
Q2 2020 | 25 | 37 | 11 | 6 | 1 |
Q3 2020 | 17 | 24 | 35 | 7 | 7 |
Q4 2020 | 28 | 32 | 31 | 14 | -1 |
Q1 2021 | 17 | 39 | 34 | 13 | 5 |
Q2 2021 | 18 | 38 | 32 | 22 | -6 |
Q3 2021 | 15 | 35 | 33 | 13 | 9 |
Q4 2021 | 12 | 36 | 20 | 33 | -17 |
Q1 2022 | 26 | 33 | 19 | 18 | -4 |
Q2 2022 | 17 | 30 | 26 | 19 | -4 |
Q3 2022 | 16 | 30 | 28 | 14 | 1 |
Q4 2022 | 7 | 35 | 23 | 15 | 1 |
Q1 2023 | 1 | 18 | 16 | 10 | -3 |
Hedge funds changes in IGM Biosciences stock options (Q3 2019 – Q1 2023)
Q3 2019 | 0 | 0 |
---|---|---|
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 39,717,000 | 43,642,000 |
Q4 2020 | 5,367,000 | 33,515,000 |
Q1 2021 | 7,079,000 | 27,463,000 |
Q2 2021 | 4,542,000 | 2,894,000 |
Q3 2021 | 18,686,000 | 2,906,000 |
Q4 2021 | 1,272,000 | 1,078,000 |
Q1 2022 | 15,025,000 | 7,911,000 |
Q2 2022 | 2,004,000 | 252,000 |
Q3 2022 | 1,536,000 | 670,000 |
Q4 2022 | 1,067,924 | 164,595 |
Q1 2023 | 19,000 | 1,000 |